Combination of Mediclinic and Al Noor

DateTitleFormat
04/03/2016Notification of statement of circumstances by KPMG LLP regarding change of auditorshttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
22/02/2016Change of accounting reference date and auditor
19/02/2016POTENTIAL TAX IMPLICATIONS OF MEDICLINIC SCHEME FOR MEDICLINIC SA SHAREHOLDERShttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
17/02/2016Second reduction of capital effectivehttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
15/02/2016Name change to Mediclinic International plc effectivehttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
15/02/2016Completion Announcementhttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
22/01/2016Announcement – First Reduction of Capital Effectivehttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
29/01/2016Announcement – Combination Unconditionalhttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
19/01/2016Update on Competition Process and Revised Timetable of Principal Eventshttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
15/12/2015Al Noor GM Results Announcementhttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
19/11/2015Publication of Prospectus, Circular and Notice of General Meeting and Trading Updatehttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
19/11/2015Class 1 and Whitewash Circular and Notice of General Meetinghttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
19/11/2015Prospectushttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
19/11/2015Form of Proxy http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
19/11/2015Documents for inspection (as listed below):
Consent letter from KPMGhttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Consent letter from PricewaterhouseCoopers LLPhttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Accountants’ and financial advisers’ reports on the Profit Forecast (Extract from Appendix 3 of the Circular) http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Unaudited pro forma financial information of the Enlarged Group (Extract from Part VII of the Circular) http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Memorandum of incorporation of Remgro Limited http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Consent letter from Jefferieshttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Consent letter from N.M. Rothschild & Sons Limitedhttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Consent letter from Goldman Sachs Internationalhttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Irrevocable undertaking from GC Hattinghhttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Assets transfer agreementhttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Proposed new remuneration policy (extract from Appendix 4 of the Circular) http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Articles of association of the Companyhttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Proposed amendments to the articles of association of the Companyhttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
The Remgro Bridge Facility Agreementhttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
The Deal Origination Fee Letter relating to the Remgro Bridge Facility Agreementhttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Deal Origination Feehttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Facility Agreementhttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Irrevocable undertaking from Sheik Mohammed Bin Butti Al Hamed http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Irrevocable undertaking from Dr Kassem Alom http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Irrevocable undertaking from Remgro http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Irrevocable undertaking from D P Meintjeshttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Irrevocable undertaking from KHS Pretoriushttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Irrevocable undertaking from CI Tinglehttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Irrevocable undertaking from CA Van der Merwehttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Irrevocable undertaking from E DE LA H Hertzoghttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Non-Disclosure Agreement between Al Noor, Mediclinic & Remgrohttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Bid Conduct Agreement between Al Noor and Mediclinic http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Subscription Agreement between Al Noor and Remgrohttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
Relationship Agreement between Al Noor and Remgrohttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
14/10/2015Link to live webcast
Investor webcast
http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
14/10/2015Recording of interviews with CEOs of Al Noor and Mediclinic
www.mediclinicalnoor.com
http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
14/10/2015Mediclinic Al Noor Investor Presentationhttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
14/10/2015Joint Transaction Announcement - Englishhttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
14/10/2015Joint Transaction Announcement - Arabichttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
05/10/2015Statement regarding possible combination http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
DateTitleFormat
19/02/2016POTENTIAL TAX IMPLICATIONS OF MEDICLINIC SCHEME FOR MEDICLINIC SA SHAREHOLDERShttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
15/02/2016Name change to Mediclinic International plc effectivehttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
15/02/2016Completion Announcementhttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
01/02/2016Al Noor Pre-listing Announcement – secondary inward listing of Al Noor on the main board of the JSEhttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
29/01/2016Competition Tribunal approval, recovery of dividends tax on Repurchase Option and finalisation announcementhttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
19/01/2016Update on competition process and revised expected timetablehttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
19/01/2016Recording of Capital Markets Day presentationshttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
19/01/2016Presentation: Capital Markets Dayhttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
15/12/2015 Results of the Mediclinic Scheme Meeting http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
15/12/2015 Results of the Takeover Special Committee Ruling concerning Remgro Healthcare http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
17/11/2015 Al Noor Prospectus to Al Noor shareholders http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
17/11/2015 Al Noor Circular to Al Noor shareholders http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
17/11/2015 Announcement regarding posting of Scheme Circular and notice of Scheme Meeting http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
17/11/2015 Al Noor Prospectus in terms of South African Companies Act to Mediclinic shareholders http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
17/11/2015 Mediclinic Scheme Circular to Mediclinic shareholders http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
14/10/2015 Investor presentation http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
14/10/2015 Link to live webcast (9:00 UK time / 10:00 SA time) http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
14/10/2015 Recording of interviews with CEOs of Al Noor and Mediclinic http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
14/10/2015 Recommendation regarding combination of Al Noor and Mediclinic http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
06/10/2015 Announcement regarding possible combination of Mediclinic and Al Noor http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
05/10/2015 Cautionary announcement http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
06/10/2015 Announcement regarding possible combination of Mediclinic and Al Noor http://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif
03/08/2015Circular relating to rights issuehttp://www.mediclinic.com/SiteCollectionImages/16x16/md_pdf.gif

IMPORTANT DISCLAIMER

ACCESS TO THIS AREA OF THE WEBSITE MAY BE RESTRICTED UNDER SECURITIES LAWS, RULES OR REGULATIONS IN CERTAIN JURISDICTIONS. THIS NOTICE REQUIRES YOU TO CONFIRM CERTAIN MATTERS (INCLUDING THAT YOU ARE NOT RESIDENT OR PHYSICALLY PRESENT IN SUCH A JURISDICTION), BEFORE YOU MAY OBTAIN ACCESS TO THE INFORMATION ON THIS AREA OF THE WEBSITE. THESE MATERIALS ARE NOT DIRECTED AT OR TO BE ACCESSED BY, OR DISTRIBUTED OR DISSEMINATED TO, DIRECTLY OR INDIRECTLY, PERSONS RESIDENT OR PHYSICALLY LOCATED IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS, RULES OR REGULATIONS OF THAT JURISDICTION OR WOULD RESULT IN A REQUIREMENT TO COMPLY WITH CONSENT OR OTHER FORMALITY WHICH MEDICLINIC REGARDS AS UNDULY ONEROUS.

Combination of Mediclinic International Limited ("Mediclinic") and Al Noor Hospitals Group plc ("Al Noor") (the "Combination")

Access to the website

You are attempting to enter the part of the website that is designated for the publication of documents and information in connection with the Combination.

If you would like to view this part of the website, please read this notice carefully. This notice applies to all persons who view this part of the website and, depending on where you are located, may affect your rights or responsibilities. Mediclinic reserves the right to amend or update this notice at any time and you should, therefore, read it in full each time you visit the site. In addition, the contents of this part of the website may be amended at any time, in whole or in part, at the sole discretion of Mediclinic.

This part of the website contains electronic versions of materials relating to the Combination. The materials you are seeking to access are made available in good faith and for information purposes only and are subject to the terms and conditions set out below. Any person seeking to access this part of the website represents and warrants to Mediclinic that they are doing so for information purposes only.

To allow you to view information about the Combination, you must read this notice and then click "I ACCEPT". If you are unable to agree, you should click "I DECLINE" and you will not be able to view information about the Combination.

The Combination would be made by means of a scheme document to be published by Mediclinic which would contain the full terms and conditions of such Combination, including details on how it may be accepted. Any decision made in relation to the Combination should be made solely and only on the basis of the information provided in any such document.

Overseas jurisdictions

Viewing the materials you are seeking to access may be restricted under securities laws in certain jurisdictions. All persons who wish to view this part of the website must first satisfy themselves that they are not subject to any local requirements which prohibit or restrict them from doing so and should inform themselves about, and observe, any legal or regulatory requirements applicable in their jurisdiction.

These materials are not directed at or intended to be accessible by persons resident in any jurisdiction if to do so would constitute a violation of the relevant laws or regulations of that jurisdiction.

YOU SHOULD NOT, DIRECTLY OR INDIRECTLY, DOWNLOAD, MAIL, FORWARD, DISTRIBUTE, SEND OR SHARE THE INFORMATION OR DOCUMENTS CONTAINED ON THIS PART OF THE WEBSITE TO ANY PERSON. IN PARTICULAR, YOU SHOULD NOT, DIRECTLY OR INDIRECTLY, MAIL, FORWARD, DISTRIBUTE OR SEND THE INFORMATION OR DOCUMENTS CONTAINED THEREIN TO ANY JURISDICTION WHERE IT WOULD BE UNLAWFUL TO DO SO. MEDICLINIC AND ITS ADVISERS DO NOT ASSUME ANY LIABILITY FOR ANY VIOLATION BY ANY PERSON OF ANY OF THESE RESTRICTIONS.

It is your responsibility to satisfy yourself as to the full observance of any relevant laws and regulatory requirements. If you are in any doubt, you should click on “I DECLINE” below and exit this webpage.

Cautionary Note Regarding Forward-Looking Statements

This part of the website and the information contained in it may contain certain forward-looking statements with respect to the financial condition, results of operations and businesses of Mediclinic and the Mediclinic Group (being Mediclinic and its subsidiaries and subsidiary undertakings) and Al Noor and the Al Noor Group (being Al Noor and its subsidiaries and subsidiary undertakings) following the Combination. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. Forward-looking statements are statements of future expectations that are based on management's current expectations and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in these statements. Forward-looking statements include, among other things, statements concerning the potential exposure of Mediclinic and the Mediclinic Group to market risks and statements expressing management's expectations, beliefs, estimates, forecasts, projections and assumptions, including as to future potential cost savings, synergies, earnings, cash flow and prospects. These forward-looking statements are identified by their use of terms and phrases such as "anticipate", "believe", "could", "estimate", "expect", "goals", "intend", "may", "objectives", "outlook", "plan", "probably", "project", "risks", "seek", "should", "target", "will" and similar terms and phrases. There are a number of factors that could affect the future operations of Mediclinic and the Mediclinic Group and Al Noor and the Al Noor Group post Combination and could cause those results to differ materially from those expressed in the forward-looking statements included in this part of the website. All forward-looking statements contained in this part of the website are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Readers should not place undue reliance on forward-looking statements. Each forward-looking statement speaks only as at the specified date of the relevant document within which the statement is contained. None of Mediclinic, the Mediclinic Group, Al Noor or the Al Noor Group undertake any obligation to publicly update or revise any forward-looking statement as a result of new information, future events or other information. In light of these risks, results could differ materially from those stated, implied or inferred from the forward-looking statements contained in this part of the website.

Responsibility

In relation to any Combination-related materials accessible on this area of the website please note any statement of responsibility contained therein.

The documents included in this part of the website issued or published by Mediclinic speak only at the specified date of the relevant document and Mediclinic has, and accepts, no responsibility or duty to update or revise such documents.

In relation to any such announcements or other Combination-related materials issued or published by Al Noor, or which relate to Al Noor and the Al Noor Group, that are accessible on this website, the only responsibility accepted by Mediclinic and its directors is for the correctness and fairness of its reproduction.

Neither the directors of Mediclinic, nor Mediclinic, nor any of their affiliated companies, have reviewed, and no such person is or shall be responsible for or accepts any liability in respect of, any information contained on any other website which may be linked to or from this part of the website.

Other

If you are in any doubt about the contents of this part of the website or the action you should take, you should seek your own financial advice from an appropriately authorised independent financial adviser.

This notice shall be governed by and construed in accordance with English law.

CONFIRMATION OF UNDERSTANDING AND ACCEPTANCE

If you are not able to give these confirmations, you should click on “I DECLINE” below and exit the webpage.